- About Us
- Services & Solutions
- Novel Technology Platform
- Bioconjugation Discovery
- Bioconjugation Process Development
- Analytical Development
- Formulation and DP Development
- GMP mAb Intermediate and Conjugation Manufacturing
- GMP Formulation, Fill and Lyophilization
- Payload and Linker R&D and Manufacturing
- Ready-Made Payloads & Linkers
- WuXi XDC Singapore Site
- Investor Relations
- News & Resources
WuXi Biologics
Offering End-to-End Solutions
- About Us
About Us - Services & SolutionsAbout Us
- Investor RelationsAbout Us
- News & ResourcesAbout Us
Press Releases
Invitation ｜WuXi XDC 2026 Interim Results and Corporate Update Call
Invitation ｜WuXi XDC 2026 Interim Results and Corporate Update Call
尊敬的投资者和分析师，
Dear Investors & Analysts,
我们诚挚邀请您参加8月25日召开的药明合联2026年中期业绩及业务进展发布会。
WuXi XDC cordially invites you to join our 2026 Interim Results and Corporate Update Call.
中文和英文的线上电话会可通过扫描下方二维码，或访问以下网址参与（需提前注册）：
Please scan the QR codes or through direct link to register and participate the calls.
中文业绩电话会 CN Earnings Call:
日期Date/时间Time：
2026年8月25日, 8:30-9:30 AM HKT
网址：
https://biologicswx.zoom.us/webinar/register/WN_Mj5kAWbcSpqJ8rvYoHiDqg
英文业绩电话会 EN Earnings Call:
日期Date/时间Time：
2026年8月25日, 20:30-21:30 PM HKT
网址：
https://biologicswx.zoom.us/webinar/register/WN_BixCq083TXiYcQ-IGuPWjw
我们期待第一时间为您解读公司2026年中期业绩及业务进展。
Notice:
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?